Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lower risk for Hodgkin's lymphoma reported to be associated with aspirin use

March 2, 2004

Good pharmacological profile and antitumor activity of topoisomerase I-active agent BMS-251873

March 2, 2004

Avastin approved for first-line metastatic colorectal cancer

March 1, 2004

Abraxane enters new studies in NSCLC and metastatic melanoma

March 1, 2004

Pharmacia claims new protein kinase inhibitors for cancer and other disorders

March 1, 2004

Two series of kinase/phosphatase inhibitors and their use in cancer and cardiovascular disorders

March 1, 2004

Hollis-Eden acquires Congressional Pharmaceutical

March 1, 2004

Diatos secures financing to advance development of DTS-201

March 1, 2004

OSI expands ongoing phase I study of OSI-461

March 1, 2004

Callisto acquires rights to novel cancer technology platform

March 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...